Hematology/Oncology 1: Pediatric Oncology

Hematology/Oncology 1: Pediatric Oncology

100 - Influence of Preferred Language on Time to Diagnosis of Pediatric Leukemia

101 - Navigating Conflicting Communication Preferences in Serious Illness: Recommendations from Pediatric Patients with Advanced Cancer, Parents, and Oncologists

102 - Outcomes after Implementation of an Emergency Department Fever and Neutropenia Protocol in Pediatric Oncology Patients

103 - Preferred Language, Acuity at Presentation, and Intensive Care Unit (ICU) Level Care in Children with Acute Myeloid Leukemia

104 - Preparation for implementation: technical and procedural challenges and adaptations for delivering an online fertility preservation decision tool to adolescents

105 - Sodium Glucose Cotransporter 2 inhibitor (SGLT2i) Use in a Pediatric Patient Receiving Cisplatin

106 - Utilization of Integrative Medicine Services among Survivors of Childhood, Adolescent and Young Adult (AYA) Cancer

091 - Bacterial (Non-Clostridium Difficile) and Parasitic Stool Studies Have Limited Utility in Pediatric Hematopoietic Stem Cell Transplant Patients

092 - Characterization and Assessment of Central Line Associated Bloodstream Infections Requiring Hospitalization in Pediatric Oncology Patients

093 - Development of a physical activity and education module-containing mobile application for pediatric cancer patients and providers

094 - Dual Inhibition of PAX3-FOXO1 in Rhabdomyosarcoma

095 - Exploratory Analysis of Kidney Injury Biomarkers in Pediatric Cancer Survivors that received Cisplatin Chemotherapy: Pilot Study

096 - Exploring Family Perspectives on Integrative and Complementary Medicine Practices in Pediatric Hematology/Oncology

097 - Genetic differences between primary and metastatic Ewing Sarcoma: implications for targeted therapeutics

098 - Immunity to Pneumococcus in Childhood Cancer Survivors

099 - Infectious Disease Risk Factors and Incidence of Bacteremia and Febrile Neutropenia During COVID-19